Drug profile · INN
etomidate
ETOMIDATE
etomidate (ETOMIDATE) is a gaba-a receptor; anion channel positive modulator. Route of administration: injection. Current US regulatory status: approved.
Drug details — etomidate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 15
- Programs
- 4
- Data quality
- 0.84
Quick answer
etomidate (ETOMIDATE) is a gaba-a receptor; anion channel positive modulator. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12171837
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 12030911
Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA
granted -
US 11746124
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11161873
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11021454
Type of aryl benzofuran amidated derivative and medical use thereof
granted -
US 10570185
Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
granted -
US 9351989
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
granted -
US 8916538
Solid forms of a thiophosphoramidate nucleotide prodrug
granted -
US 8846638
Macrocyclic nucleoside phosphoramidate derivatives
granted -
US 8759318
Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
granted -
US 8658616
Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus
granted -
US 8119779
Phosphoramidate derivatives
granted -
US 7951787
Phosphoramidate compounds and methods of use
granted -
US 7825231
Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
granted -
US 7115590
Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
granted
Frequently asked questions
What is etomidate?
etomidate (ETOMIDATE) is a gaba-a receptor; anion channel positive modulator. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for etomidate?
ETOMIDATE is a marketed brand name for etomidate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of etomidate?
etomidate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.